EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Disease burden and the role of pharmacogenomics in African populations

K L Mpye, A Matimba, K Dzobo, S Chirikure, A Wonkam, C Dandara

Global Health, Epidemiology and Genomics · 2017

DOI: 10.1017/gheg.2016.21 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Global Health, Epidemiology and Genomics, 2017. Verfasst von K L Mpye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University …. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The burden of communicable and non-communicable diseases in Sub-Saharan Africa poses a challenge in achieving quality healthcare. Although therapeutic drugs have generally improved health, their efficacy differs from individual to individual. Variability in treatment response is mainly because of genetic variants that affect the pharmacokinetics and pharmacodynamics of drugs.

Method

The intersection of disease burden and therapeutic intervention is reviewed, and the status of pharmacogenomics knowledge in African populations is explored.

Results

The most commonly studied variants with pharmacogenomics relevance are discussed, especially in genes coding for enzymes that affect the response to drugs used for HIV, malaria, sickle cell disease and cardiovascular diseases.

Conclusions

The genetically diverse African population is likely to benefit from a pharmacogenomics-based healthcare approach, especially with respect to reduction of drug side effects, and separation of responders and non-responders leading to optimized drug choices and doses for each patient.

Schlagwörter

Stichwörter der Autor:innen

Disease burdendrug metabolizing enzymesgenetic variationpharmacogeneticspharmacogenomicssub-Saharan Africa

Autor:innen und Institutionen

  • Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa.
  • Department of Clinical Pharmacology, College of Health Sciences, University of Zimbabwe, P.O. Box A178, Avondale, Harare, Zimbabwe.
  • International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Wernher and Beit Building (South), UCT Campus, Anzio Road, Observatory, 7925, Cape Town, South Africa.
  • Division of Medical Biochemistry, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa.
  • Department of Archaeology, University of Cape Town, Cape Town, Rondebosch 7701, South Africa.

Zitieren

APA

Mpye, K. L., Matimba, A., Dzobo, K., Chirikure, S., Wonkam, A., & Dandara, C. (2017). Disease burden and the role of pharmacogenomics in African populations. Global Health, Epidemiology and Genomics. https://doi.org/10.1017/gheg.2016.21

Vancouver

Mpye KL, Matimba A, Dzobo K, Chirikure S, Wonkam A, Dandara C. Disease burden and the role of pharmacogenomics in African populations. Global Health, Epidemiology and Genomics. 2017. doi:10.1017/gheg.2016.21

BibTeX
@article{Mpye2017,
  author = {Mpye, K L and Matimba, A and Dzobo, K and Chirikure, S and Wonkam, A and Dandara, C},
  title = {Disease burden and the role of pharmacogenomics in African populations},
  journal = {Global Health, Epidemiology and Genomics},
  year = {2017},
  doi = {10.1017/gheg.2016.21}
}
Kostenlos starten →